Rising total costs and mortality rates associated with admissions due to COPD exacerbations

Respiratory Research

Volumn 17, Issue 1, 2016, Pages

  Molinari, Nicolas ^a,b   Chanez, Pascal ^e,f   Roche, Nicolas ^d   Ahmed, Engi ^a   Vachier, Isabelle ^c   Bourdin, Arnaud ^a,b,c  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b Apard   (France)

^c HÔPITAL ARNAUD DE VILLENEUVE   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e AIX MARSEILLE UNIVERSITY   (France)

^f Aix Marseille University Luminy Campus   (France)

Author keywords

Admissions; COPD exacerbation; COPD management; Deaths; Hospitalizations

Indexed keywords

ACUTE RESPIRATORY FAILURE; AGE DISTRIBUTION; AGED; ARTICLE; ARTIFICIAL VENTILATION; BRONCHOSCOPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE EXACERBATION; FEMALE; FRANCE; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITAL MORTALITY; HOSPITALIZATION COST; HUMAN; INCIDENCE; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; PNEUMONIA; SEASONAL VARIATION; SEX RATIO; SPIROMETRY; THORAX RADIOGRAPHY; ECONOMICS; EPIDEMIOLOGY; FACTUAL DATABASE; HEALTH CARE QUALITY; HOSPITAL COST; LONGITUDINAL STUDY; MIDDLE AGED; MORTALITY; REGISTER; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME FACTOR; TREATMENT OUTCOME; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CRITICAL CARE; DATABASES, FACTUAL; DISEASE PROGRESSION; FEMALE; FRANCE; HOSPITAL COSTS; HOSPITAL MORTALITY; HUMANS; INCIDENCE; LENGTH OF STAY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATIENT ADMISSION; PROCESS ASSESSMENT (HEALTH CARE); PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGISTRIES; RESPIRATION, ARTIFICIAL; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84995752730     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/s12931-016-0469-6     Document Type: Article

References (27)

1. GOLD - the Global initiative for chronic Obstructive Lung Disease. at http://goldcopd.org/global-strategy-diagnosis-management-prevention-copd-2016/. Accessed 8 Nov 2016.
2. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747-57.
3. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 2004;364:613-20.
4. Devereux G. ABC of chronic obstructive pulmonary disease. Definition, epidemiology, and risk factors. BMJ. 2006;332:1142-4.
5. Holguin F, Folch E, Redd SC, Mannino DM. COmorbidity and mortality in copd-related hospitalizations in the united states, 1979 to 2001*. Chest. 2005;128:2005-11.
6. Ford ES, Croft JB, Mannino DM, Wheaton AG, Zhang X, Giles WH. COPD surveillance--United States, 1999-2011. Chest. 2013;144:284-305.
7. De Miguel-Díez J, Jiménez-García R, Hernández-Barrera V, Puente-Maestu L, Rodríguez-Rodríguez P, López De Andrés A, et al. Trends in hospital admissions for acute exacerbation of COPD in Spain from 2006 to 2010. Respir Med. 2013;107:717-23.
8. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095-128.
9. Woodruff PG, Agusti A, Roche N, Singh D, Martinez FJ. Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management. Lancet. 2015;385:1789-98.
10. Wedzicha JA, Seemungal TAR. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370:786-96.
11. Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363:1128-38.
12. Aaron SD. Management and prevention of exacerbations of COPD. BMJ. 2014;349:g5237.
13. Müllerova H, Maselli DJ, Locantore N, Vestbo J, Hurst JR, Wedzicha JA, et al. Hospitalized Exacerbations of COPD: Risk Factors and Outcomes in the ECLIPSE Cohort. Chest. 2015;147:999-1007.
14. Greening NJ, Williams JEA, Hussain SF, Harvey-Dunstan TC, Bankart MJ, Chaplin EJ, et al. An early rehabilitation intervention to enhance recovery during hospital admission for an exacerbation of chronic respiratory disease: randomised controlled trial. BMJ. 2014;349:g4315.
15. Janson C, Larsson K, Lisspers KH, Ställberg B, Stratelis G, Goike H, et al. Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting β2 agonist: observational matched cohort study (PATHOS). BMJ. 2013;346:f3306.
16. Blasi F, Cesana G, Conti S, Chiodini V, Aliberti S, Fornari C, et al. The clinical and economic impact of exacerbations of chronic obstructive pulmonary disease: a cohort of hospitalized patients. PLoS One. 2014;9:e101228.
17. Molinari N, Briand C, Vachier I, Malafaye N, Aubas P, Georgescu V, Roche N, Chanez P, Bourdin A. Hospitalizations for COPD Exacerbations: Trends and Determinants of Death. J COPD in press;doi: 10.3109/15412555.2015.1007931.
18. Wijayaratne K, Wilson J, Sivakumaran P, Sriram KB. Differences in care between general medicine and respiratory specialists in the management of patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Thorac Med. 2013;8:197-203.
19. Abroug F, Ouanes-Besbes L, Nciri N, Sellami N, Addad F, Hamda KB, et al. Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers. Am J Respir Crit Care Med. 2006;174:990-6.
20. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific allcause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Lond Engl. 2015;385(9963):117-71.
21. Baillargeon J, Wang Y, Kuo Y-F, Holmes HM, Sharma G. Temporal Trends in Hospitalization Rates for Older Adults with Chronic Obstructive Pulmonary Disease. Am J Med. 2013;126(7):607-14.
22. Zvezdin B, Milutinov S, Kojicic M, Hadnadjev M, Hromis S, Markovic M, et al. A postmortem analysis of major causes of early death in patients hospitalized with COPD exacerbation. Chest. 2009;136:376-80.
23. Janoir C, Lepoutre A, Gutmann L, Varon E. Insight Into Resistance Phenotypes of Emergent Non 13-valent Pneumococcal Conjugate Vaccine Type Pneumococci Isolated From Invasive Disease After 13-valent Pneumococcal Conjugate Vaccine Implementation in France. Open Forum Infect Dis 2016;3:ofw020.
24. Angoulvant F, Cohen R, Doit C, Elbez A, Werner A, Béchet S, et al. Trends in antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae isolated from nasopharyngeal flora in children with acute otitis media in France before and after 13 valent pneumococcal conjugate vaccine introduction. BMC Infect Dis. 2015;15:236.
25. Rabe KF, Fabbri LM, Vogelmeier C, Kögler H, Schmidt H, Beeh KM, et al. Seasonal distribution of COPD exacerbations in the Prevention of Exacerbations with Tiotropium in COPD trial. Chest. 2013;143:711-9.
26. Almagro P, Soriano JB, Cabrera FJ, Boixeda R, Alonso-Ortiz MB, Barreiro B, et al. Short- and medium-term prognosis in patients hospitalized for COPD exacerbation: the CODEX index. Chest. 2014;145:972-80.
27. Jeppesen E, Brurberg KG, Vist GE, Wedzicha JA, Wright JJ, Greenstone M, Walters JAE. Hospital at home for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012;5:CD003573.